基础研究

LncRNA FAM83A-AS1通过miR-150/HMGA2轴对视网膜母细胞瘤细胞增殖和凋亡的影响

  • 周小平 ,
  • 彭正武 ,
  • 陈书扬 ,
  • 刘茹 ,
  • 田涛 ,
  • 欧玉仑
展开
  • 郴州市第一人民医院眼科 (湖南 郴州 423000 )

收稿日期: 2023-02-22

  网络出版日期: 2023-12-11

基金资助

湖南省卫健委科研课题(202207022509)

Effect of lncRNA FAM83A-AS1 on proliferation and apoptosis of retinoblastoma cells through miR-150/HMGA2 axis

  • Xiaoping ZHOU ,
  • Zhengwu PENG ,
  • Shuyang CHEN ,
  • Ru LIU ,
  • Tao TIAN ,
  • Yulun. OU
Expand
  • Department of Ophthalmology,The First People′s Hospital of Chenzhou,Chenzhou 423000,China

Received date: 2023-02-22

  Online published: 2023-12-11

摘要

目的 探讨长链非编码RNA(lncRNA)序列相似家族83成员A-反义核糖核酸1(FAM83A-AS1)在视网膜母细胞瘤(RB)细胞中的作用及其潜在的分子机制。 方法 体外培养RB细胞,将Vector、pcDNA-FAM83A-AS1、NC-siRNA、FAM83A-AS1-siRNA分别转染至细胞中(依次为pcDNA?FAm83A?AS1组、NC-siRNA组、FAm83A-AS1-siRNA组),检测RB细胞中FAM83A-AS1的表达、RB细胞增殖能力、凋亡率。生物信息学方法和双荧光素酶报告基因实验预测和验证FAM83A-AS1与miR-150以及miR-150与高迁移率族蛋白A2(HMGA2)的靶向关系。RT-qPCR检测RB细胞中miR-150、HMGA2 mRNA的表达;Western blot检测RB细胞中HMGA2蛋白的表达;MTT实验和流式细胞术检测转染后RB细胞增殖和凋亡能力。 结果 pcDNA-FAM83A-AS1组细胞中FAM83A-AS1的表达显著高于Vector组,低于NC-siRNA组(P < 0.05)。pcDNA-FAM83A-AS1组较Vector组的细胞增殖能力显著升高,细胞凋亡率显著降低(P < 0.05)。FAM83A-AS1-siRNA组较NC-siRNA组的细胞增殖能力显著降低,细胞凋亡率显著升高(P < 0.05)。miR-150 mimic可显著抑制RB细胞增殖能力,促进细胞凋亡。而pcDNA-HMGA2可显著逆转miR-150 mimic对RB细胞增殖和凋亡的作用。 结论 敲低lncRNA FAM83A-AS1通过调控miR-150/HMGA2轴抑制RB细胞增殖,促进细胞凋亡。

本文引用格式

周小平 , 彭正武 , 陈书扬 , 刘茹 , 田涛 , 欧玉仑 . LncRNA FAM83A-AS1通过miR-150/HMGA2轴对视网膜母细胞瘤细胞增殖和凋亡的影响[J]. 实用医学杂志, 2023 , 39(22) : 2934 -2940 . DOI: 10.3969/j.issn.1006-5725.2023.22.013

Abstract

Objective To investigate the role of long non-coding RNA family with sequence similarity 83 member A antisense RNA 1 in retinoblastoma (RB) cells and its potential molecular mechanism. Methods RB cells were cultured in vitro, and Vector, pcDNA-FAM83A-AS1, NC-siRNA, and FAM83A-AS1-siRNA were transfected into cells to detect the expression of FAM83A-AS1, RB cell proliferation ability, and apoptosis rate in RB cells. Bioinformatics and dual-luciferase reporter gene experiments were performed to predict and verify the targeting relationship between FAM83A-AS1 and miR-150, and miR-150 and the high-mobility family protein A2 (HMGA 2). The expression of miR-150 and HMGA2 mRNA in RB cells was measured by RT-qPCR; HMGA 2 protein in RB cells by Western blot; and the proliferation and apoptotic capacity of RB cells after transfection by MTT assay and flow cytometry. Results The expression of FAM83A-AS1 in the pcDNA-FAM83A-AS1 group was significantly higher than that of the Vector group and lower than that of the NC-siRNA group (P < 0.05). The cell proliferation capacity in the pcDNA-FAM83A-AS1 group was significantly higher, and the apoptosis rate was significantly lower (P < 0.05). Compared with NC-siRNA group, FAM83A-AS1-siRNA group showed significantly increased apoptosis rate (P < 0.05). The miR-150 mimic significantly inhibited the proliferation capacity of RB cells and promoted cell apoptosis. However, pcDNA-HMGA 2 significantly reversed the effect of miR-150 mimic on the proliferation and apoptosis of RB cells. Conclusion Knockdown of lncRNA FAM83A-AS1 inhibited RB cell proliferation and promoted apoptosis by regulating the miR-150/HMGA2 axis.

参考文献

1 GUPTA H, MALAICHAMY S, MALLIPATNA A, et al. Retinoblastoma genetics screening and clinical management[J].BMC Med Genomics, 2021, 14(1):188.
2 SCHAIQUEVICH P, FRANCIS J H, CANCELA M B, et al. Treatment of retinoblastoma: What is the latest and what is the future[J].Front Oncol, 2022, 12:822330.
3 KOPP F, MENDELL J T. Functional classification and experimental dissection of long noncoding RNAs[J].Cell, 2018, 172(3):393-407.
4 TANIUE K, AKIMITSU N. The functions and unique features of LncRNAs in cancer development and tumorigenesis[J]. Int J Mol Sci, 2021, 22(2):632.
5 ZHANG A, SHANG W, NIE Q, et al. Long non-coding RNA H19 suppresses retinoblastoma progression via counteracting miR-17-92 cluster[J]. J Cell Biochem, 2018, 119(4):3497-3509.
6 HAN N, ZUO L, CHEN H, et al. Long non-coding RNA homeobox A11 antisense RNA (HOXA11-AS) promotes retinoblastoma progression via sponging miR-506-3p[J]. Onco Targets Ther, 2019, 12:3509-3517.
7 WANG W, ZHAO Z, XU C, et al. LncRNA FAM83A-AS1 promotes lung adenocarcinoma progression by enhancing the pre-mRNA stability of FAM83A[J]. Thorac Cancer, 2021, 12(10):1495-1502.
8 XIAO G, WANG P, ZHENG X, et al. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14[J]. Cell Cycle, 2019, 18(21):2972-2985.
9 LIN W, ZHOU Q, WANG C Q, et al. LncRNAs regulate metabolism in cancer[J]. Int J Biol Sci, 2020, 16(7):1194-1206.
10 DINESCU S, IGNAT S, LAZAR A D, et al. Epitranscriptomic signatures in lncRNAs and their possible roles in cancer[J]. Genes (Basel), 2019, 10(1):52.
11 HUANG G M, ZANG H L, GENG Y X, et al. LncRNA FAM83A-AS1 aggravates the malignant development of esophageal cancer by binding to miR-495-3p[J]. Eur Rev Med Pharmacol Sci, 2020, 24(18):9408-9415.
12 WU J, QIAN D, SUN X. Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis[J]. Cancer Cell Int,2020,20:201.
13 FENG W, ZHU R, MA J, et al. LncRNA ELFN1-AS1 promotes retinoblastoma growth and invasion via regulating miR-4270/SBK1 axis[J]. Cancer Manag Res, 2021, 13:1067-1073.
14 HE H, QIN M. Long non-coding RNA LEF1-AS1 is involved in the progression of retinoblastoma through regulating the Wnt/β-catenin pathway[J]. Clin Exp Pharmacol Physiol, 2020, 47(5):886-891.
15 CHEN Z, HU Z, SUI Q, et al. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma[J]. Int J Biol Sci,2022,18(2):522-535.
16 ZHAO H, WANG Y, WU X, et al. FAM83A antisense RNA 1 (FAM83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPKɑ signaling in lung adenocarcinoma[J]. Bioengineered,2022,13(5):13312-13327.
17 朱岱阳,杜洋,范培芝. lncRNAs在甲状腺癌中的研究进展[J]. 实用医学杂志,2020,36(8):1116-1120.
18 LUO H, XU C, LE W, et al. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150[J]. J Cell Biochem, 2019, 120(8):13487-13493.
19 ZHAO Y, YUAN D, ZHU D, et al. LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p[J]. J Ovarian Res, 2021, 14(1):109.
20 HUANG G M, ZANG H L, GENG Y X, et al. LncRNA FAM83A-AS1 aggravates the malignant development of esophageal cancer by binding to miR-495-3p[J]. Eur Rev Med Pharmacol Sci, 2020, 24(18):9408-9415.
21 HUANG H, YANG C, ZHANG Q, et al. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression[J]. Bioengineered, 2022, 13(3):4964-4977.
22 SONG J, SUN Y, CAO H, et al. A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma[J]. Bioengineered,2021,12(1):5932-5949.
23 KONAR G J, FERGUSON C, FLICKINGER Z, et al. miRNAs and Müller Glia Reprogramming During Retina Regeneration[J]. Front Cell Dev Biol, 2021,8:632632.
24 FAN H, LIU X, ZHENG W W, et al. MiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1[J]. Eur Rev Med Pharmacol Sci, 2020, 24(14):7544.
25 LI Z, ZHOU X, HUANG J, et al. miR-150-5p inhibits nasopharyngeal cancer genesis by suppressing PYCR1[J]. Am J Med Sci, 2022, S0002-9629(22)00268-3.
26 LI W, WANG J, ZHANG D, et al. MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway[J]. Cancer Biomark, 2019, 25(1):79-88.
文章导航

/